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The first paragraph (144 words). 
Glycosphingolipids (GSLs) synthesized in Golgi apparatus by sequential transfer of 
sugar residues to a ceramide lipid anchor are ubiquitously distributing on vertebrate 
plasma membranes.  Standardized method allowing for high throughput structural 
profiling and functional characterization of living cell surface GSLs is of growing 
importance because they function as crucial signal transduction molecules in various 
processes of dynamic cellular recognitions.  However, methods are not available for 
amplification of GSLs, while the genomic scale PCR amplification permits large-scale 
mammalian genomics and proteomics. Here we communicate such an approach to a 
novel “omics”, namely glycosphingolipidomics based on the glycoblotting method.  
The method, which involves selective ozonolysis of the C-C double bond in ceramide 
moiety and subsequent enrichment of generated GSL-aldehydes by chemical ligation 
using aminooxy-functionalized gold nanoparticle (aoGNP) should be of widespread 
utility for structural identification and functional characterization of whole GSLs present 
in the living cells/tissues.  
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Main text (1424 words). 
Cell surface GSLs exhibit various and crucial functions in cell growth, differentiation, 
adhesion, and malignant alteration1.  It has been documented that dramatic changes in 
GSL composition and metabolism are strongly associated with oncogenic 
transformation2,3.  Therefore, identification of disease-related structural alteration of 
cell surface GSLs will become a key to develop diagnostic biomarkers and therapeutic 
anticancer vaccines.  However, purification and structural characterization of cellular 
GSLs have not been routinely possible to date, typically requiring tedious and 
time-consuming extraction/purification steps of GSLs of interest from extremely 
complex mixtures before analysis.  In general, protocols for the isolation of GSLs would 
vary depending upon the analytical methods as well as chemical properties of individual 
GSLs and would need specialized expertise at step-by-step/case-by-case handling for 
separation.  These crucial problems in the enrichment of whole GSLs make it difficult to 
achieve high throughput structural and functional analyses of biologically important 
GSLs.  In addition, we should pay attention to the fact that cell surface GSLs often 
exhibit specific biological functions through dynamic mechanism such as clustering or 
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self-assembling in order to amplify the affinity with partner molecules.  For example, 
it was suggested that tumor-associated GSLs are locating at high density in tumor cells 
and may be organized in microdomains at the tumor cell surface4,5.  It seems that self- 
assembly of GSLs might become an essential mechanism to serve their immunogenicity 
and antigenicity1.  We thought that a practical method allowing both for structural 
profiling and for functional analysis of GSLs as key component of cell surface 
microdomain is now strongly expected. 
We have demonstrated the versatility of chemical ligation of reactive carbonyl 
groups by means of aminooxy- or hydrazine-functionalized polymers in selective 
enrichment analysis of whole N-glycans6-12 and some kinds of glycopeptides8,13 derived 
from human serum, cellular glycoproteins, and biopharmaceuticals.  The new concept 
of “glycoblotting”, a glycan enrichment technology based on the above chemical 
ligation, greatly facilitated further quantitative and large-scale glycomics and 
glycoproteomics using general mass spectrometry-based analyses for the purpose of 
exploring clinically potential biomarkers11-13.   
On the other hand, it is well known that metal and semi-conducting nanoparticles 
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are nice tools of the scaffold materials displaying various biomolecules through the 
specific Au-S bonding14.  Since these nanoparticles conjugated with biomolecules are 
soluble or well dispersed in aqueous solution and stable under physiological conditions, 
they have been widely applied in broad scientific fields of biochemistry and chemical 
biology for the molecular recognition assay15,16.  Metal nanoparticles have also been 
used as a matrix for LDI-MS analysis, where the metal particles serve as a reservoir for 
photon energy deposition17,18.  Advantages of the use of gold nanoparticle (GNP) in 
MALDI-TOFMS based structural characterization may be summarized as follows: (a) 
GNP exhibits much greater ionization efficiency than common organic matrices due to 
the quantum coefficient effect19, (b) self assembled monolayer (SAM) of thiol 
compound chemisorbed onto the Au surface can be ionized efficiently to cleave the 
Au-S bond by laser irradiation in the MALDI process20, and (c) conjugating 
mass-limited small molecules onto the colloidal Au surface makes it possible to 
sequester and transfer small quantities of analytes with high efficiency21.  Recent our 
results revealed that ionization of analytes is highly enhanced by specific 
laser-scattering or diffused reflection on the extremely increased surface area of metal 
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nanoparticles, which may greatly accelerate the ionization of chemisorbed small 
molecules from GNP22,23.  We hypothesized that a streamlined protocol by integrating 
above two technologies, “glycoblotting and GNP-assisted MALDI-TOFMS”, makes an 
enrichment analysis of living cell surface glycosphingolipids possible.  Here we 
communicate for the first time a comprehensive approach of structural and functional 
glycosphingolipidomics based on glycoblotting method.   
Naturally occurring GSLs commonly involve a trans-double bond at C-4,5 position 
of the sphingosine base moiety, which can be cleaved quantitatively by simple 
ozonolysis to generate aldehyde derivatives of the parent GSLs (Figure 1).  This 
characteristic feature of GSLs prompted us to establish novel and standardized method 
allowing for structural and functional glycosphingolipidomics concurrently.  Figure 
2(a) illustrates a general strategy for the selective enrichment of cellular GSLs onto 
GNP surface by applying the concept of glycoblotting.  We devised high performance 
and well dispersed GNP having aminooxy functional groups (aoGNP) by reduction of 
Au3+ ion (KAuCl4) with NaBH4 in the mixed solution of methanol and water in the 
presence of stabilizing reagents 11,11'-dithio bis[(undec-11-yl)- 
 7
12-(N-{tert-butoxycarbonyl}aminooxyacetyl)amino hexa(ethyleneglycol)] (1) and 
1,1’-dithio bis[undec-11-yl hexa(ethylene glycol)] (2).  The average diameter of 
aoGNP was estimated to be 1.3 nm, indicating that an aoGNP is composed of 79 Au 
atoms and covered with 38 thiol molecules (The synthesis of compounds 1, 2, and 
MS-based characterization of aoGNP are described in the Supplementary 
Information).  It was revealed that the oxime bonds formed between GSL-aldehydes 
and aminooxy groups of aoGNP can be readily cleaved by laser irradiation under 
common MALDI condition to afford highly sensitive iminoalcohol ions [Figure 2(b)].  
To illustrate the new method, crude lipids fraction24 of C57BL/6JJcl adult (7 weeks) and 
embryonic (13.5 days) mouse brains were subjected directly to “ozonolysis” and 
“glycoblotting” protocol.  Reaction of GSL-aldehydes with aoGNPs proceeded 
smoothly under mild condition without any special reagent.  After simple purification 
GSLs transferred onto aoGNPs (GSLs-GNPs) were employed directly for further 
structural characterization.  The merit of this method is evident because whole 
procedure from GSLs enrichment to mass spectrometry-based structural profiling can 
be performed within 3~4 hours by employing approximately 100 mg (wet weight) of 
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mouse brain.  As anticipated, MALDI-TOFMS showed that aoGNP captures four 
major gangliosides such as GM1 (m/z 1411.5), GD1a/GD1b (m/z 1702.6), and GT1b 
(m/z 1993.6) found in general adult mouse brain and GD3 (m/z 1272.6) found mainly in 
embryonic mouse brain [Figure 3(a)-(c)]25.  When GSLs enriched similarly on aoGNP 
from mouse B16 melanoma cells (1.7 x 107 cells) were subjected to MALDI-TOFMS, 
multiple ion peaks corresponding to GM3 analogs having various long acyl chains were 
detected at m/z 1037.9 (h18:0), 1065.9 (21:0 or h20:0), 1081.9 (h21:0), 1093.4 (23:0 or 
h22:0), 1110.0 (h23:0), 1124.1 (h24:0), and 1140.1 (2h24:0) [Figure 4(a)].  This result 
clearly indicates that the present protocol greatly facilitated analysis of the molecular 
diversity (microheterogeneity) of GSLs in terms of alterations in N-acyl groups as well 
as glycoforms [Figure 4(b)].  
    Next, our interest was focused on the feasibility of aoGNPs as a platform for the 
characterization of carbohydrate-carbohydrate interaction conducted by cell surface 
glycosphingolipids26.  It seems that whole GSLs enriched on the GNPs might become 
a plausible model of the living cell “microdomain” involving high-density GSLs and 
serves as nice tools for investigating specific functions of self-assembled GSLs under a 
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similar topology to the intact plasma membrane.  Here we examined the feasibility of 
aoGNPs for functional analysis of above mentioned B16 cell surface GSLs because it 
was documented that GM3 is identified as the melanoma-associated antigen in mice, 
hamsters and humans27 and microdomain composed of highly expressed GM3 in mouse 
melanoma B16 cells28 intermediates cancer metastasis through the specific adhesion 
with Gg3Cer29,30.  In addition to GSLs(B16)-GNPs [whole GSLs on aoGNP enriched 
from mouse B16 melanoma cells described in the above MS analyses (Figure 4)], we 
prepared GSLs-GNPs displaying pure GalCer, LacCer, GM1, and GM3 as controls.  
The calibration curves were also made by using these authentic GSLs-GNPs to 
determine the amount of total GSLs enriched from B16 cells on the GNPs.  The 
concentration of GSLs-GNPs was estimated by means of pulsed amperometric analysis 
using high-pH anion-exchange column chromatography (HPAE-PAD, Supplementary 
Methods).  The results indicated that approximately 7~16 molecules of GSLs are 
captured on the surface of the single aoGNP, respectively (the average surface area of 
the single GNP = 5.3 nm2).  Thus, well-characterized GSLs-GNPs were employed for 
further binding assay using surface plasmon resonance (SPR) with LB-membrane of 
 10
gangliotriaosylceramide (Gg3Cer) immobilized on gold substrate.  It was revealed that 
the binding profile of GSLs(B16)-GNPs seems to be quite similar to that of GM3-GNPs 
and the affinity constants (Ka) were calculated by applying above equation to be 4.35 × 
105 M-1 for GSLs(B16)-GNPs and 3.64 × 105 M-1 for GM3-GNPs, respectively (Figure 
5).  On the other hand, the binding curves of other GSLs-GNPs such as GalCer-GNPs, 
LacCer-GNPs, and GM1-GNPs did not fit to above Langmuir-type isothermal 
adsorption equation, indicating that they are non-specific binding.  These results 
clearly suggest that the binding of GM3-GNPs or GSLs(B16)-GNPs with Gg3Cer 
monolayer is a specific and high affinity interaction30.   
In conclusion, we demonstrated that aoGNPs are suited scaffold material for the 
chemical enrichment (glycoblotting) and subsequent MALDI-TOFMS-based structural 
characterization of naturally occurring GSLs.  Conceptually, this is the first approach 
to permit high throughput structural profiling of living cell/tissue GSLs.  This new 
protocol, in combination with nanoparticles-based molecular imaging/sensing 
technology, should help to expedite a novel class glycosphingolipidomics and discovery 
research of disease-related biomarkers.   
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METHODS (114 words). 
Ozonolysis and enrichment of mouse brain GSLs. Crude lipids fraction of 
C57BL/6JJcl adult (7 weeks) and embryonic (13.5 days) mouse brain extracted by using 
Ladisch solvent24 [diisopropyl ether/1-butanol/50 mM NaCl aq. (6/4/5, v/v/v)] was 
subjected directly to the treatment with O3 for 30 min and quenched with 
triphenylphosphine.  The solution containing GSL-aldehydes was washed with 
diisopropyl ether/1-butanol (3/2, v/v) to remove simple alkyl aldehyde as by-product.  
Then, the mixture was allowed to react with aoGNPs in 50 mM sodium acetate buffer 
(pH 4.0 at ambient temperature).  After evaporating to complete oxime-bond formation, 
GSLs-GNPs were collected, washed thoroughly by using simple ultrafiltration, and 
employed directly for MALDI-TOFMS.  For the full protocols see the Supplementary 
Information. 
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Figure and Scheme Legend 
Figure 1. Chemical structures of major glycosphingolipids used in this study. 
Figure 2. (a) A general strategy for structural and functional glycosphingolipidomics 
based on the selective enrichment of cellular GSLs onto aoGNP surface by applying the 
concept of glycoblotting. (b) Oxime bonds formed between GSL-aldehydes and 
aoGNPs are digested selectively by laser irradiation on MALDI process to afford highly 
sensitive iminoalcohol ions. 
Figure 3. Profiling mouse brain glycosphingolipids by glycoblotting and subsequent 
MALDI-TOFMS. (a) GSLs identified in adult mouse brain (upper panel) and 
embryonic mouse (bottom panel). (b) MALDI-TOF/TOFMS analysis of the selected 
peak at m/z 1411.5 (GM1), 1702.6 (GD1a/GD1b), and 1993.6 (GT1b) observed in adult 
mouse brain. (c) MALDI-TOF/TOFMS of a precursor ion at m/z 1272.6 corresponding 
to GD3 detected in embryonic mouse brain.   
Figure 4. Profiling whole GSLs enriched from mouse B16 melanoma cells (C57BL/6). 
(a) MALDI-TOFMS exhibited multiple ion peaks due to GSLs mixture observed in a 
range from m/z 1037.9 to 1140.1. (b) MALDI-TOF/TOFMS of a selected peak at m/z 
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1093.4 revealed that these GSLs are GM3 analogs having various N-acyl chains. 
Figure 5. SPR analysis of GSL-GSL interaction on the basis of aoGNPs as a platform 
for displaying high-density GSLs (microdomains). GSLs-GNPs displaying whole GSLs 
from B16 mouse melanoma cells (-●-) or authentic (purified) GSLs such as GalCer 
(-◆-), LacCer (-■-), GM1 (-☓-), and GM3 (-▲-) were employed as analytes for 
SPR-based binding assay with LB-membrane of Gg3Cer. Affinity constants (Ka) were 
calculated by using a common Langmuir-type equation: [GSLs]/ΔRU = [GSLs]/ΔRUmax 
+ 1/ΔRUmaxKa.  Here, ΔRUmax means the maximal changes in the SPR upon the 
injection of the GSLs-GNPs.  [GSLs] is the concentration of GSLs-GNPs and adjusted 
to be 0.01, 0.1, 0.5, 1.0, 2.5, 5.0, 7.5, and 10 μM.   
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